Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
However, they received an FDA warning letter in February 2026 for misleading labeling on their website
Your body has never experienced pharmaceutical glucagon receptor agonism at these potencies
Foundayo, Lilly's weekly weight loss pill, was approved by the Food and Drug Administration and made available in April, and is one of two oral GLP-1 medications approved by the agency -- Wegovy is the other one
Conflict of interest FG received research support from Eli Lilly, LifeScan, and Takeda and served as a consultant and author for AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp and Dohme, Novo Nordisk, Roche Diabetes Care, and Sanofi
Your body produces thousands of them
